Hanmi achieved growth at 37% of sales and 56% of operating income

Published: 2004-11-05 06:58:00

Updated: 2004-11-05 06:58:00

Hanmi has achieved a remarkable growth up to the 3rd quarter of this year, thank to the favorable sales increase and successful launching of new products, showing 37.1% up of sales at 233,500 million won compared to the same period last year of 170,300 million won (Jan. 1 to Sept. 30) and 56.9% u...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK